膜マーカー - Centre National de la Reselsch Shantifik

Title:

膜マーカー

Document Type and Number:

Japanese Patent JP7083820

Kind Code:

B2

Abstract:

The use of differentiation marker CD32 for the detection of cellular reservoirs of a mammalian immunodeficiency virus. Also the use of the differentiation marker CD32 for making a prognosis, diagnosing a remission, and evaluating the efficacy of treatment of the mammalian immunodeficiency. A multi-specific antibody that recognizes both at least one epitope of CD32 and at least one characteristic of the lymphocyte cells, a composition including the antibody, and the use of the antibody in treatment.

More Like This:

WO/2000/050069	A MEANS FOR THE PROPHYLACTIC AND THERAPEUTIC TREATMENT OF STREPTOCOCCAL INFECTIONS
JP2002506983	Description: Assay for detecting substances having anti-HIV activity
WO/2015/128396	METHOD FOR MOLECULAR DIAGNOSTICS FOR ENRICHING A NUCLEIC ACID FROM A BIOLOGICAL SAMPLE

Inventors:

Moncef, Benkirane
Frog and Petit Jean
Benjaman, decourt

Application Number:

JP2019517354A

Publication Date:

June 13, 2022

Filing Date:

September 30, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Centre National de la Reselsch Shantifik
DEINOVE

International Classes:

G01N33/569; A61K39/395; A61K45/00; A61P31/18; A61P43/00; C07K16/28; C07K16/46; C12N5/10; C12Q1/02; C12Q1/686; C12Q1/6888; G01N33/50; G01N33/53

Domestic Patent References:

JP2005507635A
JP2000505091A

Foreign References:

US7192582
WO1998002463A1
WO2016118456A1

Other References:

PETITJEAN, G. et al,Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk,JOURNAL OF CLINICAL VIROLOGY,2007年03月26日,Vol.39/No.1,p.1-8

Attorney, Agent or Firm:

Hiroyuki Nagai
Nakamura Yukitaka
Satoru Asakura
Asano Mari
Sorimachi Hiroshi
Hirosuke Endo

Previous Patent: Cell marker

Next Patent: Equipment and related methods for illuminating objects with controlled light intensity